From: Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment
Treated with antifibrotics before coded IPF diagnosis (N = 1,205) | Treated with antifibrotics after coded IPF diagnosis (N = 3,444) | Untreated (N = 40,242) | Total (N = 44,891) | p value | |
---|---|---|---|---|---|
Age | < 0.0001 | ||||
Mean (SD) | 77.4 (4.9) | 76.9 (4.7) | 79.0 (5.5) | 78.8 (5.4) | |
Median | 77.0 | 77.0 | 80.0 | 80.0 | |
Age Group | < 0.001 | ||||
Less than 65 | 14 (1.9) | 35 (4.8) | 676 (93.2) | 725 (1.6) | |
65–74 | 320 (3.5) | 1,071 (11.6) | 7,824 (84.9) | 9,215 (20.5) | |
75–84 | 794 (2.7) | 2,212 (7.6) | 26,288 (89.7) | 29,294 (65.3) | |
Over 85 | 77 (1.4) | 126 (2.2) | 5,454 (96.4) | 5,657 (12.6) | |
Gender | < 0.001 | ||||
Female | 472 (2.1) | 1,257 (5.5) | 21,046 (92.4) | 22,775 (50.7) | |
Male | 733 (3.3) | 2,187 (9.9) | 19,196 (86.8) | 22,116 (49.3) | |
Race/Ethnicity | 0.0039 | ||||
White | 1,139 (2.7) | 3,248 (7.8) | 37,274 (89.5) | 41,661 (92.8) | |
Hispanic | 30 (2.3) | 85 (6.6) | 1,175 (91.1) | 1,290 (2.9) | |
Black | 14 (1.6) | 44 (4.9) | 833 (93.5) | 891 (2.0) | |
Other | 22 (2.1) | 67 (6.4) | 960 (91.5) | 1,049 (2.3) | |
Census Region | < 0.001 | ||||
Midwest | 311 (2.8) | 857 (7.7) | 9,999 (89.5) | 11,167 (24.9) | |
Northeast | 186 (2.6) | 511 (7.0) | 6,597 (90.4) | 7,294 (16.2) | |
South | 525 (2.8) | 1,555 (8.3) | 16,571 (88.8) | 18,651 (41.5) | |
West | 181 (2.4) | 520 (6.8) | 6,948 (90.8) | 7,649 (17.0) | |
History of Tobacco Use | 772 (64.1) | 1,975 (57.3) | 22,657 (56.3) | 25,404 (56.6) | < 0.001 |